vitaly goranov

vitaly goranov


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
VGvitaly goranov
vitaly goranov
TSTATIANA SHELYAKOVA
TATIANA SHELYAKOVA
RSR. De Santis
R. De Santis
YHY. Haranava
Y. Haranava
AMA. Makhaniok
A. Makhaniok
Valentin Alek DediuValentin Alek Dediu
Valentin Alek Dediu
A three dimensional magnetic patterning of two cell types was realised in vitro inside an additive manufactured magnetic scaffold, as a conceptual precursor for the vascularised tissue. The realisation of separate arrangements of vascular and osteoprogenitor cells, labelled with biocompatible magnetic nanoparticles, was established on the opposite sides of the scaffold fibres under the effect of non-homogeneous magnetic gradients and loading magnetic configuration. The magnetisation of the scaffold amplified the guiding effects by an additional trapping of cells due to short range magnetic forces. The mathematical modelling confirmed the strong enhancement of the magnetic gradients and their particular geometrical distribution near the fibres, defining the preferential cell positioning on the micro-scale. The manipulation of cells inside suitably designed magnetic scaffolds represents a unique solution for the assembling of cellular constructs organised in biologically adequate arrangements.

5 November 2021 in Polymers
Verified
Journal Article
Open access
PDF file
Mauro PetrettaMauro Petretta
Mauro Petretta
AGAlessandro Gambardella
Alessandro Gambardella
GDGiovanna Desando
Giovanna Desando
CCCarola Cavallo
Carola Cavallo
IBIsabella Bartolotti
Isabella Bartolotti
Brunella GrigoloBrunella Grigolo
Brunella Grigolo
Multifunctional and resistant 3D structures represent a great promise and a great challenge in bone tissue engineering. This study addresses this problem by employing polycaprolactone (PCL)-based scaffolds added with hydroxyapatite (HAp) and superparamagnetic iron oxide nanoparticles (SPION), able to drive on demand the necessary cells and other bioagents for a high healing efficiency. PCL-HAp-SPION scaffolds with different concentrations of the superparamagnetic component were developed through the 3D-printing technology and the specific topographical features were detected by Atomic Force and Magnetic Force Microscopy (AFM-MFM). AFM-MFM measurements confirmed a homogenous distribution of HAp and SPION throughout the surface. The magnetically assisted seeding of cells in the scaffold resulted most efficient for the 1% SPION concentration, providing good cell entrapment and adhesion rates. Mesenchymal Stromal Cells (MSCs) seeded onto PCL-HAp-1% SPION showed a good cell proliferation and intrinsic osteogenic potential, indicating no toxic effects of the employed scaffold materials. The performed characterizations and the collected set of data point on the inherent osteogenic potential of the newly developed PCL-HAp-1% SPION scaffolds, endorsing them towards next steps of in vitro and in vivo studies and validations.

17 October 2013 in BioSystems
Verified
Journal Article
Closed access
VGvitaly goranov
vitaly goranov
YHY. Haranava
Y. Haranava
VGV. Goranov
V. Goranov
PSPanseri Sara
Panseri Sara
SSS. Semerikhina
S. Semerikhina
Valentin Alek DediuValentin Alek Dediu
Valentin Alek Dediu


28 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
VGvitaly goranov
vitaly goranov
Nanocarrier medicine has entered a paradox. The chemistry to make targeted, multi-functional carriers is now routine, and the clinical need - most sharply in cancers such as colorectal carcinoma - is unambiguous, yet fewer than one in ten preclinical candidates reaches patients, and the fraction of an injected dose that reaches a solid tumour remains small. The bottleneck is not synthetic capacity but interpretation: nanocarrier physicochemistry, in vitro biological behaviour and patient-level clinical variability are measured in disconnected assays, and no single framework couples them into an actionable prediction for a specific patient. We propose that this coupling is best cast as a three-layer virtual twin. Layer 1 is the nanocarrier physicochemical feature space (size, shape, coating, corona, payload). Layer 3 is the patient biological profile drawn from routine clinical-laboratory data (molecular status, tumour markers, systemic-inflammation indices). Between them sits Layer 2, an intermediate integrating layer of multi-modal AI/ML biosensing. We formalise the concept, show how each layer is populated with concrete quantitative examples (drawn from a validated microfluidic biosensing platform and from published colorectal-cancer laboratory data), and argue that a personalised, safety-gated decision index emerges naturally from the fusion. We conclude with a maturation trajectory that turns this concept into a practical instrument for personalised nanomedicine.

15 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
VGvitaly goranov
vitaly goranov
YHYulija Haranava
Yulija Haranava
The capacity of engineered nanoparticles (NPs) to traverse biological barriers is a central determinant of efficacy in nanomedicine, targeted drug delivery and nanotoxicology, yet it remains one of the least reproducibly measured properties in the field. Established characterisation methods — Transwell® permeability assays, inductively coupled plasma atomic emission spectroscopy (ICP-AES), fluorescence microscopy and flow cytometry — each suffer from low throughput, marked inter-laboratory variability, or a dependence on particle labelling that perturbs the physicochemical properties governing transport. We describe and validate a fully integrated platform that couples a commercially available cross-flow microfluidic chamber bearing sequential porous-membrane cell barriers with label-free brightfield microscopy and a five-stage artificial-intelligence / machine-learning (AI/ML) pipeline. Intracellular NP accumulation, principally within lysosomes, produces characteristic organelle darkening that is detected without labelling, segmented by a residual-attention U-Net (ResAt-UNet; IoU = 0.85, precision = 93.2%, recall = 86.9%) and converted into quantitative transport-efficiency (TE) and barrier-integrity metrics. Across a factorial matrix of two surface chemistries, five core sizes (15–150 nm), four concentrations (10–500 µg mL⁻¹), two human barriers (HUVEC and hCMEC/D3) and two magnetic-field states (0 T, 1 T), PLGA-coated 15 nm SPIONs at 100 µg mL⁻¹ achieved the highest TE — 10.8 ± 1.5% (HUVEC) and 3.4 ± 0.6% (hCMEC/D3) at 0 T, rising to 13.2 ± 1.6% and 4.1 ± 0.7% under 1 T magnetic guidance (a realistic +22% relative gain). A dynamic three-zone quality-control (QC) architecture, gating every transport datum on matched transendothelial electrical resistance (TEER) and viability. Multi-factor ANOVA identified barrier identity, core size and coating as the dominant determinants of TE (all p < 0.001; partial η² = 0.43, 0.41 and 0.32, respectively). Gradient-boosted modelling with SHapley Additive exPlanations (SHAP) reproduced this ranking and, critically, showed that QC filtering raised cross-validated R² from 0.74 to 0.85 — establishing that the QC architecture materially improves predictive performance rather than cosmetically tidying the data.